Dihydropyridine-Insensitive Calcium Currents Contribute to Function of Small Cerebral Arteries
Open Access
- 3 February 2010
- journal article
- research article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 30 (6), 1226-1239
- https://doi.org/10.1038/jcbfm.2010.11
Abstract
Although dihydropyridines are widely used for the treatment of vasospasm, their effectiveness is questionable, suggesting that other voltage-dependent calcium channels (VDCCs) contribute to control of cerebrovascular tone. This study therefore investigated the role of dihydropyridine-insensitive VDCCs in cerebrovascular function. Using quantitative PCR and immunohistochemistry, we found mRNA and protein for L-type (CaV1.2) and T-type (CaV3.1 and CaV3.2) channels in adult rat basilar and middle cerebral arteries and their branches. Immunoelectron microscopy revealed both L- and T-type channels in smooth muscle cell (SMC) membranes. Using patch clamp electrophysiology, we found that a high-voltage-activated calcium current, showing T-type channel kinetics and insensitivity to nifedipine and nimodipine, comprised ∼20% of current in SMCs of the main arteries and ∼45% of current in SMCs from branches. Both components were abolished by the T-type antagonists mibefradil, NNC 55-0396, and efonidipine. Although nifedipine completely blocked vasoconstriction in pressurized basilar arteries, a nifedipine-insensitive constriction was found in branches and this increased in magnitude as vessel size decreased. We conclude that a heterogeneous population of VDCCs contributes to cerebrovascular function, with dihydropyridine-insensitive channels having a larger role in smaller vessels. Sensitivity of these currents to nonselective T-type channel antagonists suggests that these drugs may provide a more effective treatment for therapy-refractory cerebrovascular constriction.Keywords
This publication has 51 references indexed in Scilit:
- Alternative splicing of Cav1.2 channel exons in smooth muscle cells of resistance-size arteries generates currents with unique electrophysiological propertiesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Heterogeneity of L- and T-Channels in the VasculatureHypertension, 2009
- Alternative splicing within the I–II loop controls surface expression of T‐type Cav3.1 calcium channelsFEBS Letters, 2008
- The Role of L- and T-Type Calcium Channels in Local and Remote Calcium Responses in Rat Mesenteric Terminal ArteriolesJournal of Vascular Research, 2008
- A Smooth Muscle Cav1.2 Calcium Channel Splice Variant Underlies Hyperpolarized Window Current and Enhanced State-dependent Inhibition by NifedipinePublished by Elsevier BV ,2007
- Voltage-dependent calcium channels of dog basilar arteryThe Journal of Physiology, 2007
- Profiling the array of Cav3.1 variants from the human T‐type calcium channel gene CACNA1G: Alternative structures, developmental expression, and biophysical variationsProteins-Structure Function and Bioinformatics, 2006
- Antihypertensive Effects of the Putative T-Type Calcium Channel Antagonist Mibefradil Are Mediated by the L-Type Calcium Channel Ca v 1.2Circulation Research, 2006
- Physiological genomics in PG and beyond: October to December 2005Physiological Genomics, 2006
- T‐channel‐like pharmacological properties of highvoltage‐activated, nifedipine‐insensitive Ca2+ currents inthe rat terminal mesenteric arteryBritish Journal of Pharmacology, 2002